Multiple-dose ponezumab for mild-to-moderate Alzheimer's disease: Safety and efficacy.

Saved in:
Bibliographic Details
Title: Multiple-dose ponezumab for mild-to-moderate Alzheimer's disease: Safety and efficacy.
Authors: Landen JW; Pfizer Inc., Groton, CT, USA., Cohen S; Toronto Memory Program, Toronto, Ontario, Canada., Billing CB Jr; Pfizer Inc., Groton, CT, USA., Cronenberger C; Pfizer Inc., Groton, CT, USA., Styren S; Pfizer Inc., Groton, CT, USA., Burstein AH; Pfizer Inc., Groton, CT, USA., Sattler C; Pfizer Inc., Groton, CT, USA., Lee JH; Department of Neurology, Asan Medical Center, Seoul, Korea., Jack CR Jr; Department of Radiology, Mayo Clinic, Rochester, MN, USA., Kantarci K; Department of Radiology, Mayo Clinic, Rochester, MN, USA., Schwartz PF; Pfizer Inc., Groton, CT, USA., Duggan WT; Pfizer Inc., Groton, CT, USA., Zhao Q; Pfizer Inc., Groton, CT, USA., Sprenger K; Pfizer Inc., Groton, CT, USA., Bednar MM; Pfizer Inc., Cambridge, MA, USA., Binneman B; Pfizer Inc., Cambridge, MA, USA.
Source: Alzheimer's & dementia (New York, N. Y.) [Alzheimers Dement (N Y)] 2017 May 10; Vol. 3 (3), pp. 339-347. Date of Electronic Publication: 2017 May 10 (Print Publication: 2017).
Publication Type: Journal Article
Journal Info: Publisher: Wiley on behalf of the Alzheimer's Association Country of Publication: United States NLM ID: 101650118 Publication Model: eCollection Cited Medium: Print ISSN: 2352-8737 (Print) Linking ISSN: 23528737 NLM ISO Abbreviation: Alzheimers Dement (N Y) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2352-8737
DOI:10.1016/j.trci.2017.04.003